Powassan virus was first identified in 1958, when a 5-year-old boy died of encephalitis in Powassan, Ontario, Canada. The first US case followed in New Jersey in 1970. For the next 40 years the disease was a North American curiosity with one or two human cases per year. Since 2016, US Powassan cases have climbed to 39 in 2022 and 47 in 2023, with the heaviest concentration in Massachusetts, Minnesota, Wisconsin, New York, Maine, and New Jersey.

Powassan does what Lyme does not: it transmits in 15 minutes of tick attachment versus Lyme's 24 to 36 hours, has no licensed treatment, and kills 10 percent of clinical cases. About half of survivors live with permanent neurological deficits. This post fits inside the outbreak-aware travel guide and complements Lyme disease tick prevention and tick-borne encephalitis.

Key Takeaways

What is Powassan virus?

Powassan virus is a tick-borne flavivirus, the only one of its kind known to circulate naturally in North America. It is a close relative of tick-borne encephalitis virus circulating in Europe and Asia. Two lineages are recognized: Lineage 1 (classic Powassan, primarily in mammals like groundhogs and foxes) and Lineage 2 (deer tick virus, primarily in white-footed mice and the dominant US lineage today).

The virus was first isolated in 1958 from the brain of a deceased boy in Powassan, Ontario. Lineage 2 was identified in the 1990s in Ixodes scapularis ticks in the eastern US and now accounts for the majority of human cases.

Both lineages cause indistinguishable clinical disease. Diagnosis as Powassan versus deer tick virus is rarely made at the clinical level.

How is it transmitted?

Ixodes scapularis (the blacklegged or deer tick) is the dominant vector for Lineage 2 in the US, the same tick that transmits Lyme disease, anaplasmosis, babesiosis, and Borrelia miyamotoi. Ixodes cookei transmits Lineage 1 from groundhogs and other small mammals.

The 15-minute transmission window is the critical clinical fact. Lyme bacteria need 24 to 36 hours of tick attachment to migrate from the gut to the salivary glands. Powassan virus is already in the salivary glands and transmits with the saliva almost as soon as the tick begins feeding. Standard "check yourself daily" tick prevention works for Lyme but is much less effective for Powassan.

White-footed mice (Peromyscus leucopus) are the dominant amplifying reservoir. Deer maintain the tick population but are not viral amplifiers. The transmission cycle is similar to Lyme but with different viral dynamics.

Where is Powassan active?

US case distribution since 2015 concentrates in seven states:

State Cases 2017-2023
Minnesota 50+
Wisconsin 35+
Massachusetts 30+
New York 25+
Maine 20+
New Jersey 15+
Connecticut 10+

The geographic distribution overlaps heavily with Lyme disease but extends further north into Canada (Ontario, Quebec, Manitoba, Saskatchewan, Atlantic provinces). The Far East Russia and Primorsky region see cases of related tick-borne flaviviruses.

Cases peak from May through October with the highest months being June, July, and August. Late spring nymph-stage ticks are the most consistent transmitters because nymphs are small (poppy seed sized) and often attach unnoticed.

What are the symptoms?

Symptoms appear 1 week to 1 month after tick exposure. Most infections are mild or asymptomatic, but clinical disease is severe.

The clinical picture is encephalitis or meningoencephalitis with focal features. Brain MRI shows lesions in the thalamus, basal ganglia, cerebellum, and brainstem. CSF shows mild lymphocytic pleocytosis and elevated protein typical of viral encephalitis.

Mortality runs 10 percent of clinically apparent cases. Of survivors, around 50 percent have lasting neurological sequelae: cognitive impairment, weakness, headaches, recurrent seizures. Full recovery within weeks happens but is the minority outcome.

How is it diagnosed?

Powassan is rarely the first consideration in summer encephalitis cases. Differential diagnoses that get tested first include herpes simplex encephalitis, West Nile virus, and bacterial meningitis. Powassan testing is often added after other causes are excluded.

Diagnosis requires:

Most US clinical labs do not run Powassan serology in-house. Specimens get shipped to CDC's Arbovirus Diseases Branch in Fort Collins or to state public health laboratories. Turnaround can be 1 to 2 weeks, often after the acute illness has resolved.

The PCR vs antigen vs serology post covers how these test types differ.

How do you prevent it?

Tick avoidance is the only effective measure. There is no vaccine and no prophylactic medication.

Before outdoor exposure:

After potential exposure:

If you find an attached tick:

Unlike Lyme, prompt tick removal does not reliably prevent Powassan transmission because the 15-minute window has often passed by the time the tick is found. Removal is still essential but cannot be relied on as the sole defense. Read more in the Lyme tick prevention guide.

Why are cases rising?

Several factors contribute. Ixodes scapularis populations have expanded northward and into suburban areas, driven by white-tailed deer population recovery, fragmented forest habitat, and milder winters. White-footed mouse populations correlate with acorn masting years, creating multi-year cycles in tick-borne disease incidence.

Surveillance has also improved. Many older Powassan cases were probably misclassified as undifferentiated viral encephalitis before serology became routine. Some of the apparent rise reflects better detection rather than actual incidence increase.

Climate change extends tick activity into shoulder seasons. Mild winters allow more ticks to survive, and earlier springs and later falls give them more questing time. The climate change post covers parallel patterns across tick-borne diseases.

FAQ

How likely is Powassan after a tick bite?

Even in high-risk states, the per-bite probability of Powassan is very low. Estimated prevalence of Powassan virus in Ixodes scapularis ticks ranges from 1 to 10 percent across high-risk regions. Most bites do not result in infection, and most infections do not become symptomatic. The 15-minute transmission window applies to ticks already infected, which is the minority.

Can you test a tick for Powassan?

Some labs offer tick-borne pathogen testing on removed ticks. The clinical utility is limited. A negative tick test does not rule out infection from a different bite. A positive tick test does not guarantee transmission. CDC does not recommend tick testing for clinical decisions about prophylaxis.

Is Powassan more dangerous than Lyme?

Per case, yes. Powassan has 10 percent mortality and 50 percent rate of permanent sequelae in symptomatic cases. Lyme is rarely fatal and most cases recover fully with antibiotics. Powassan is much rarer in absolute case counts but more severe in clinical impact.

Are there any treatments under development?

No specific antivirals are in late-stage trials in 2026. Investigational use of IVIG and ribavirin has been reported in case series with unclear benefit. Vaccine development has focused more on tick-borne encephalitis in Europe and Asia; a Powassan-specific vaccine is not a near-term prospect.

Can pets get Powassan?

Dogs can be infected based on serological surveys. Clinical disease in dogs is rare and the diagnostic challenge mirrors humans. Veterinary tick prevention products that kill ticks within hours of attachment may not prevent Powassan, since transmission occurs within 15 minutes. Tick checks on dogs after rural exposure still matter.